NuVasive to launch new spine device: 5 takeaways

Written by Mackenzie Garrity | July 10, 2018 | Print  | Email

After receiving FDA approval earlier this year, NuVasive plans to unveil its XLIF Lordotic Expandable (XLX) Interbody System at the International Meeting on Advanced Spine Techniques, July 11 to 14 in Los Angeles.

Here are five takeaways:

1. The XLIF anterior column realignment technique uses controlled lordotic expansion and multifunctional instrumentation, and partnered with the XLX system, it offers a unique alternative to open surgery.

2. NuVasive incorporated its integrated global alignment software, which can calculate alignment parameters, and its preoperative planning tools NuvaLine and NuvaMap.

3. The interbody system is intended for use in the lumbar spine, from L1 to S1, for the treatment of symptomatic disc degeneration or degenerative spondylolisthesis at one or two adjacent levels.

4. The XLIF XLX Interbody System is the company's first lateral expandable. It joins NuVasive's two existing expandable interbody systems, TLX and MLX.

5. NuVasive will offer the new system in a comprehensive range of lengths and heights with up to 30 degrees of customizable lordosis.

More articles on devices and implants:
More than just outcomes — Predictive analytics provide support through the surgical continuum
Moving from art to science brings new possibilities to spine surgery
Globus Medical, SeaSpine & more: 5 device company notes

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.